Response to rapamycin

pathway activity — cross-omics
GO:1901355Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Response to rapamycin pathway is significantly associated with the protein abundance of multiple proteins, with the HNSC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are ASH2L, TRIM22_S384, and HLA-F, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Response to rapamycin activity versus ASH2L in HNSC (Pearson r = 0.28).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
HNSCASH2L →+0.213+0.073.004.00735
HNSCTRIM22_S384 →-0.847-0.056.004.00226
BRCAHLA-F →-0.463-0.036<.001<.00135
PDACBAK1 →-0.443-0.043.003<.00135
BRCAFMNL1_S184 →-0.800-0.048<.001<.00135
HNSCRAB9A →-0.280-0.088<.001.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1901355 vs ASH2L — HNSC

Per-sample scatter of Response to rapamycin activity vs ASH2L in HNSC.

Explore this scatter interactively →

Exploration